Document:

Exhibit 10.1

 

 

 

  

 

STOCK PURCHASE AGREEMENT

 

between

 

BIOSCRIP, INC.

 

and

 

THE INVESTORS NAMED HEREIN

 

Dated March 1, 2017

 

 

 

 

 

     

     

    

 

Table
of Contents

 

	 	 	 	Page

	ARTICLE 1	 	SALE AND PURCHASE; CLOSING	1
	1.1	 	 	  Authorization of Issuance and Sale	1
	1.2	 	 	Commitment to Purchase the Purchased Securities	1
	1.3	 	 	Payment of the Purchase Price for the Purchased Securities	1
	1.4	 	 	Closing of the Purchased Securities	1
	ARTICLE 2	 	REPRESENTATIONS AND WARRANTIES OF THE COMPANY	2
	2.1	 	 	Reporting Compliance	2
	2.2	 	 	Incorporation and Good Standing of the Company and its Subsidiaries	2
	2.3	 	 	Legal Power and Authority; Noncontravention; No Injunctions	2
	2.4	 	 	Authorization of Agreements; Enforceability	3
	2.5	 	 	No Consents	3
	2.6	 	 	No Material Misstatement or Omission	3
	ARTICLE 3	 	REPRESENTATIONS OF THE INVESTORS	3
	3.1	 	 	Existence and Good Standing; Authority	3
	3.2	 	 	Authorization of Agreements; Enforceability	4
	3.3	 	 	Accredited Investor	4
	3.4	 	 	Knowledge of Business; Reliance on Own Investigation	4
	3.5	 	 	Investment Intent	4
	3.6	 	 	No Manipulation or Stabilization of Price	4
	3.7	 	 	Compliance with Securities Laws	4
	3.8	 	 	Share Ownership	5
	ARTICLE 4	 	CONDITIONS TO CLOSING	5
	4.1	 	 	Conditions to Obligations of the Investors for Closing	5
	4.2	 	 	Conditions to Obligations of the Company for Closing	6
	ARTICLE 5	 	INDEMNIFICATION	6
	5.1	 	 	Indemnification by the Company	6
	5.2	 	 	Indemnification by the Investors	7

 

    -i-

     

    

 

Table
of Contents

(continued)

 

	 	 	 	Page

	ARTICLE 6	 	MISCELLANEOUS	8
	6.1	 	 	Construction	8
	6.2	 	 	Fees and Expenses	8
	6.3	 	 	Assignment; Parties in Interest	8
	6.4	 	 	Entire Agreement; Severability	9
	6.5	 	 	No Third-Party Beneficiaries	9
	6.6	 	 	Notices	9
	6.7	 	 	Amendments; Waivers	10
	6.8	 	 	Counterparts	10
	6.9	 	 	Headings	10
	6.10	 	 	Governing Law; Consent to Jurisdiction and Venue; Waiver of Jury Trial	10

 

    -ii-

     

    

 

INDEX OF SCHEDULES & EXHIBITS

 

Exhibits

 

		Exhibit A:	Registration Rights Agreement

		Exhibit B:	Exemption Letter Agreement

		Exhibit C:	Form of Opinion of Company Counsel

 

 

Schedules

 

		Schedule 1.2:	Investor Allocations

 

    -iii-

     

    

 

THIS STOCK PURCHASE
AGREEMENT dated as of March 1, 2017 (this “Agreement”), by and among BioScrip, Inc., a Delaware corporation
(the “Company”), Venor Capital Master Fund Ltd., Map 139 Segregated Portfolio of LMA SPC, Venor Special Situations
Fund II LP and Trevithick LP (each, an “Investor” and, collectively, the “Investors”).

 

RECITALS

 

WHEREAS, the Company
desires to sell to the Investors, and the Investors desire to purchase from the Company (i) 3,300,000 shares (the “Offered
Shares”) of common stock of the Company, par value $0.0001 per share (“Common Stock”); and

 

WHEREAS, the Company
intends to use the net proceeds from the offer and sale of the Offered Shares pursuant to the terms of this Agreement (the “Offering”)
for general corporate purposes.

 

NOW THEREFORE, in consideration
of the foregoing and of the agreements set forth below, the parties agree as follows:

 

ARTICLE 1

SALE AND PURCHASE; CLOSING

 

1.1             
Authorization of Issuance and Sale. Subject to the terms and conditions hereof, the Company has authorized the issuance
and sale of the Offered Shares (the “Purchased Securities”).

 

1.2             
Commitment to Purchase the Purchased Securities. Subject to the terms and conditions of this Agreement, the Investors
hereby agree to purchase from the Company the Offered Shares, and the Company hereby agrees to issue and deliver to the Investors
stock certificates representing the Shares. Schedule 1.2 sets forth the number of Shares to be purchased by each Investor
(each such number of Offered Shares, an “Investor’s Allocation”).

 

1.3             
Payment of the Purchase Price for the Purchased Securities. All payments pursuant to this Section 1.3 shall
be made by each Investor by wire transfer of immediately available funds to the Company. The account for payment shall be designated
by the Company to the Investors at least one business day prior to the Closing Date. On the Closing Date each Investor shall pay
such dollar amount equal to the product of (a) $1.5366 (the “Per Share Purchase Price”) multiplied
by (b) the Investor’s Allocation (collectively, for all Investors, the “Shares Purchase Price”).

 

1.4             
Closing of the Purchased Securities. The closing of the purchase and sale of the Purchased Securities (the “Closing”)
shall take place simultaneously with the execution of this Agreement via e-mail by means of PDF copies of signed documents (with
the original signed documents to be delivered promptly after Closing), or at such other time and by such other means as shall be
agreed to by the Company and the Investors (such date, the “Closing Date”).

 

     

     

    

 

ARTICLE 2

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

The Company hereby
represents and warrants to the Investors as of the date hereof as follows:

 

2.1             
Reporting Compliance. The Company has timely filed or furnished, as applicable, all forms, statements, certifications,
reports and documents required to be filed or furnished by it with the Securities and Exchange Commission (“SEC”)
pursuant to the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934,
as amended (the “Exchange Act”). For the avoidance of doubt, except where the context otherwise requires, as
used in this Article 2, the term “Company” refers to the Company and all of its subsidiaries on a consolidated basis.

 

2.2             
Incorporation and Good Standing of the Company and its Subsidiaries. The Company and each of the Subsidiaries (i) has
been duly organized or formed, as the case may be, is validly existing and is in good standing under the laws of its jurisdiction
of organization, (ii) has all requisite power and authority to carry on its business and to own, lease and operate its properties
and assets as described in the forms, statements, certifications, reports and documents required to be filed with or furnished
to the SEC by the Company prior to the date hereof (“Company SEC Reports”) and (iii) is duly qualified
or licensed to do business and is in good standing as a foreign corporation, partnership or other entity as the case may be, authorized
to do business in each jurisdiction in which the nature of such businesses or the ownership or leasing of such properties requires
such qualification, except where the failure to be so qualified or, solely with respect to the Subsidiaries, in good standing would
not, individually or in the aggregate, have a material adverse effect on (A) the properties, business, prospects, operations,
earnings, assets, liabilities or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, (B) the
ability of the Company or any Subsidiary to perform its obligations in all material respects under any Transaction Document (as
defined below), (C) the validity or enforceability of any of the Transaction Documents, or (D) the consummation of any
of the Transactions (as defined below) (each, a “Material Adverse Effect”).

 

2.3             
Legal Power and Authority; Noncontravention; No Injunctions.

 

(a)               
The Company has all necessary power and authority to execute, deliver and perform its obligations under the Transaction
Documents and to consummate the Transactions, and no stockholder actions or other approvals are necessary for the Company’s
execution, delivery and performance of its obligations under the Transaction Documents and to consummate the Transactions. The
consummation of the Transactions contemplated will not conflict with nor result in a violation of the Company’s certificate
of incorporation or by-laws or any laws or regulations applicable to the Company.

 

(b)              
No injunction or order has been issued that would prevent or suspend the issuance or sale of any of the Offered Shares in
any jurisdiction or would prevent the offer and sale of the Offered Shares pursuant to this Agreement or the subsequent filing
of a registration statement with the SEC to register resales of the Purchased Securities as contemplated by the form of registration
rights agreement attached hereto as Exhibit A (the “Registration Rights Agreement” and together with this Agreement
and the form of letter agreement attached hereto as Exhibit B (the “Exemption Letter”), the “Transaction
Documents”), and no proceeding for either such purpose has commenced or is pending or, to the knowledge of the Company,
is threatened.

 

    2

     

    

 

2.4             
Authorization of Agreements; Enforceability. Each of this Agreement, the Registration Rights Agreement and the Exemption
Letter has been duly and validly authorized, executed and delivered by the Company and constitutes a legal, valid and binding obligation
of the Company a, enforceable against the Company in accordance with its terms, except that the enforcement thereof may be subject
to (i) bankruptcy, insolvency, reorganization, receivership, moratorium, fraudulent conveyance, fraudulent transfer or other
similar laws now or hereafter in effect relating to creditors’ rights generally, (ii) general principles of equity (whether
applied by a court of law or equity) and the discretion of the court before which any proceeding therefor may be brought and (iii) with
respect to the rights to indemnity or contribution hereunder, federal and state securities laws and public policy considerations.

 

2.5             
No Consents. No consent, approval, authorization, order, filing or registration of or with any U.S. or non-U.S. federal,
state, local or other governmental or regulatory authority, governmental or regulatory agency or body, court, arbitrator or self-regulatory
organization (each, a “Governmental Authority”) or third party is required for execution, delivery or performance
of the Transaction Documents or the consummation of the Transactions, except (i) those that have been official or made, as
the case may be, that are in full force and effect, (ii) as may be required under any federal securities laws or the securities
or “Blue Sky” laws of U.S. state or non-U.S. jurisdictions and (iii) as may be required by the rules of The
NASDAQ National Market.

 

2.6             
No Material Misstatement or Omission. The Company SEC Reports filed on or after March 3, 2016 as of the respective
dates upon which they were filed with the SEC (and as updated by information contained in subsequent filings by the Company with
the SEC) did not include any untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading, and the financial statements included (or
to be included) therein (as updated by information contained in subsequent filings by the Company with the SEC) fairly present,
in all material respects, the consolidated financial position of the Company as of the dates indicated therein and the results
of the Company’s operations, changes in stockholders’ equity and cash flows for the periods specified therein.

 

ARTICLE 3

REPRESENTATIONS OF THE INVESTORS

 

Each Investor, severally
and not jointly, represents to the Company as follows:

 

3.1             
Existence and Good Standing; Authority. Such Investor is validly existing and in good standing under the laws of
the state of its formation and has all requisite power and authority to carry on its business as now conducted.

 

    3

     

    

 

3.2             
Authorization of Agreements; Enforceability. Each of this Agreement, the Registration Rights Agreement and the Exemption
Letter has been duly and validly authorized, executed and delivered by such Investor. Each of this Agreement and the Exemption
Letter is valid, binding and enforceable against such Investor in accordance with its terms, subject to (i) bankruptcy, insolvency,
reorganization, receivership, moratorium, fraudulent conveyance, fraudulent transfer or other similar laws now or hereafter in
effect relating to creditors’ rights generally, (ii) general principles of equity (whether applied by a court of law
or equity) and the discretion of the court before which any proceeding therefor may be brought and (iii) with respect to the
rights to indemnity or contribution hereunder, federal and state securities laws and public policy considerations.

 

3.3             
Accredited Investor. Such Investor is an “accredited investor” as that term is defined in Regulation
D promulgated under the Securities Act.

 

3.4             
Knowledge of Business; Reliance on Own Investigation. Such Investor has knowledge and experience in financial and
business matters; is familiar with the investments of the type that it is undertaking to purchase; is fully aware of the problems
and risks involved in making an investment of this type; and is capable of evaluating the merits and risks of this investment.
Such Investor has evaluated the merits and risks of the transactions contemplated by this Agreement. In deciding to purchase the
Offered Shares pursuant to this Agreement, such Investor has not relied, and will not hereafter rely, on the Company or any of
its affiliates, representatives, agents or financial, legal or other professional advisers with respect to any of such matters,
except for those representations and warranties of the Company expressly set forth in Article 2. Such Investor acknowledges
that (i) the Company currently intends to publicly disclose information about its financial results for the period ending December
31, 2016, on March 3, 2017, and (ii) such disclosure may contain information that is materially different from the Company’s
current public filings.

 

3.5             
Investment Intent. Such Investor is acquiring the Purchased Securities in the ordinary course of its business and
for its own account, with the intention of holding such shares for investment purposes and with no present intention of participating,
directly or indirectly, in a distribution of such shares in violation of applicable securities laws.

 

3.6             
No Manipulation or Stabilization of Price. Such Investor has not taken and will not take, directly or indirectly,
any action designed to, or that would constitute or that might reasonably be expected to, cause or result in, under the Exchange
Act or otherwise, stabilization or manipulation of the price of any security of the Company in order to facilitate the sale or
resale of any securities of the Company, and such Investor is not aware of any such action taken or to be taken by any person.

 

3.7             
Compliance with Securities Laws. Such Investor will not, directly or indirectly, offer, sell, pledge, transfer or
otherwise dispose of (or solicit any offers to buy, purchase or otherwise acquire or take a pledge of) any of the Purchased Securities
except in compliance with the Securities Act, and the rules and regulations promulgated thereunder, and such Investor acknowledges
that certificates representing such the Purchased Securities shall bear the following legend:

 

    4

     

    

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE OFFERED, SOLD,
TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE ACT, AN OPINION
OF COUNSEL SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT OR UNLESS SUCH OFFER, SALE, TRANSFER
OR HYPOTHECATION IS IN COMPLIANCE WITH THE REQUIREMENTS OF RULE 144 PROMULGATED UNDER THE ACT.

 

3.8             
Share Ownership. As of the date of this Agreement, except as described in the Exemption Letter, neither such Investor
nor any of its Affiliates owns, directly or indirectly, beneficially (as such term is used in Rule 13d-3 promulgated under the
Exchange Act) or of record, any capital stock or other securities of the Company or any options, warrants or other rights to acquire
capital stock or other securities of, or any other economic interest (through derivative securities or otherwise) in, the Company
except pursuant to this Agreement.

 

ARTICLE 4

CONDITIONS TO CLOSING

 

4.1             
Conditions to Obligations of the Investors for Closing. The Investors acknowledge that the following conditions have
been satisfied, or have been waived on or before Closing:

 

(a)               
Registration Rights Agreement. The Company shall have executed and delivered to the Investors the Registration Rights
Agreement, in the form attached hereto as Exhibit A.

 

(b)              
Exemption Letter. The Company shall have executed and delivered to the Investors the Exemption Letter, in the form
attached hereto as Exhibit B.

 

(c)               
Required Consents. All consents, approvals and other actions of, and notices and filings with, all Governmental Authorities
and other third parties, as may be necessary or required under law or any contract to which the Company is a party with respect
to the execution and delivery by the parties of the Transaction Documents and the consummation by the parties of the transactions
contemplated thereby, shall have been obtained or made, except for any filings, consents and approvals required under any federal
or state securities laws required to be made following Closing.

 

(d)              
Authorizing Actions of the Company. The Investors shall have received certified copies of all requisite corporate
actions taken by the Company to authorize the Company’s execution and delivery of the Transaction Documents to which it is
a party and its consummation of the transactions contemplated thereby, and such other documents and other instruments as the Investors
or their counsel may reasonably request.

 

    5

     

    

 

(e)               
Opinion of Counsel. The Investors shall have received from Dechert LLP, counsel to the Company, a legal opinion,
dated as of the Closing Date delivered together with this Agreement.

 

4.2             
Conditions to Obligations of the Company for Closing. The Company acknowledges that the following conditions have
been satisfied, or have been waived on or before Closing:

 

(a)               
Compliance with Covenants. The Investors shall have performed and complied in all material respects with all agreements
and covenants contained in the Transaction Documents as of the Closing Date.

 

(b)              
Registration Rights Agreement. The Investors shall have executed and delivered to the Company the Registration Rights
Agreement, in the form attached hereto as Exhibit A.

 

(c)               
Exemption Letter. The Investors shall have executed and delivered to the Company the Exemption Letter, in the form
attached hereto as Exhibit B.

 

(d)              
Required Consents. All consents, approvals and other actions of, and notices and filings with, all Governmental Authorities
as may be necessary or required with respect to the execution and delivery by the parties of the Transaction Documents and the
consummation by the parties of the transactions contemplated thereby, shall have been obtained or made, including all filings,
consents and approvals required under any state securities laws.

 

ARTICLE 5

INDEMNIFICATION

 

5.1             
Indemnification by the Company. The Company shall indemnify, defend and hold the Investors and their Affiliates and
each officer, director, member, partner, Affiliate, employee, agent and representative of the Investors (collectively, “Investor
Indemnitees”) harmless against all liability, loss, and damage (including taxes thereon) together with all reasonable
and properly documented costs and expenses related thereto (including reasonable and properly documented legal fees and expenses),
relating to or arising from any breach of any of the representations, warranties, covenants or agreements of the Company contained
in the Transaction Documents. In the event that any Investor Indemnitee claims any such right of indemnification, such Investor
Indemnitee shall provide to the Company written notice thereof, together with reasonable detail regarding such claims and in the
event that such claim involves third party claims, allow the Company at its expense to defend such claim(s) on the Investor Indemnitee’s
behalf. The Company shall promptly reimburse each Investor Indemnitee for any reasonable and properly documented legal and any
other necessary expenses incurred by such Investor Indemnitee in connection with investigating and defending any such expense,
loss, judgment, claim, damage, liability or action, but only to the extent incurred prior to the assumption by the Company of the
defense thereof. Any reimbursement by the Company under this Section 5.1 shall be within sixty (60) days, provided that
any individual expense in excess of $10,000 shall require the Company’s prior approval. Notwithstanding the foregoing, the
Company reserves the right to withhold approval where in the good faith judgment of the Company, the expenses are not reasonable
or properly documented.  The Company agrees that it will not, without the Investor Indemnitee’s prior written consent,
settle or compromise any claim or consent to entry of any judgment in respect thereof in any pending or threatened action, suit,
claim or proceeding in respect of which indemnification has been sought hereunder unless such settlement or compromise includes
an unconditional release of such Investor Indemnitee from all liability arising out of such action, suit, claim or proceeding.
The obligations of the Company under this Article 5 shall survive Closing and the transfer, conversion, exchange or redemption
of any Offered Shares; provided, however, that the obligations of the Company under this Article 5 with respect to breach of the
representations contained in Sections 2.1, 2.3(b), 2.5 and 2.6 shall expire one (1) year from the date
hereof. Notwithstanding anything contained in the Transaction Documents to the contrary, the Company shall not be liable to any
Investor Indemnitee for any consequential, incidental, indirect, special, exemplary or punitive damages of such Investor Indemnitee
relating to any matters for which indemnification is provided for under this Article 5, other than any such damages arising
from a claim of a third party. Except for intentional fraud, the provisions of this Article 5 are intended to and shall
provide for the exclusive monetary remedy for any and all Investor Indemnitees for the matters for which an Investor Indemnitee
may be indemnified under this Article 5 following Closing.

 

    6

     

    

 

5.2             
Indemnification by the Investors. Each Investor shall, severally, not jointly, indemnify, defend and hold the Company
and their Affiliates and each officer, director, member, partner, Affiliate, employee, agent and representative of the Company
(collectively, “Company Indemnitees”) harmless against all liability, loss, and damage (including taxes thereon)
together with all reasonable and properly documented costs and expenses related thereto (including reasonable and properly documented
legal fees and expenses), relating to or arising from any breach of any of the representations, warranties, covenants or agreements
of the Investors contained in the Transaction Documents. In the event that any Company Indemnitee claims any such right of indemnification,
such Company Indemnitee shall provide to such Investor written notice thereof, together with reasonable detail regarding such claims
and in the event that such claim involves third party claims, allow such Investor at its expense to defend such claim(s) on the
Company Indemnitee’s behalf. Such Investor shall promptly reimburse the Company Indemnitee for any reasonable and properly
documented legal and any other necessary expenses incurred by the Company Indemnitee in connection with investigating and defending
any such expense, loss, judgment, claim, damage, liability or action, but only to the extent incurred prior to the assumption by
such Investor of the defense thereof. Any reimbursement by the Investor under this Section 5.2 shall be within sixty (60)
days, provided that any individual expense in excess of $10,000 shall require such Investor’s prior approval.  Notwithstanding
the foregoing, such Investor reserves the right to withhold approval where in the good faith judgment of such Investor, the expenses
are not reasonable or properly documented.  The Company agrees that it will not, without the Company Indemnitee’s prior
written consent, settle or compromise any claim or consent to entry of any judgment in respect thereof in any pending or threatened
action, suit, claim or proceeding in respect of which indemnification has been sought hereunder unless such settlement or compromise
includes an unconditional release of such Company Indemnitee from all liability arising out of such action, suit, claim or proceeding.
The obligations of such Investor under this Article 5 shall survive Closing and the transfer, conversion, exchange or redemption
of any Offered Shares. Notwithstanding anything contained in the Transaction Documents to the contrary, such Investor shall not
be liable to any Company Indemnitee for any consequential, incidental, indirect, special, exemplary or punitive damages of such
Company Indemnitee relating to any matters for which indemnification is provided for under this Article 5, other than any
such damages arising from a claim of a third party. Except for fraud, the provisions of this Article 5 are intended to and
shall provide for the exclusive monetary remedy for any and all Company Indemnitees for the matters for which a Company Indemnitee
may be indemnified under this Article 5 following Closing.

 

    7

     

    

 

ARTICLE 6

MISCELLANEOUS

 

6.1             
Construction. Unless the context of this Agreement otherwise requires, (a) words of any gender are deemed to
include the other gender; (b) words using the singular or plural number also include the plural or singular number, respectively;
(c) the terms “hereof,” “herein,” “hereby,” “hereto” and derivative or similar
words refer to this Agreement as a whole and not to any particular provision; (d) the terms “Article,” “Section,”
“Schedule” and “Exhibit” refer to the specified Article or Section of or Schedule or Exhibit to this Agreement;
(f) the term “including” and other forms of such term, with respect to any matter or thing, mean “including
but not limited to” such matter or thing; (g) the term “control” shall include, without limitation, the
possession, directly or indirectly, of the power to direct the management and policies of a person, whether through the ownership
of voting securities, by contract or otherwise; (h) all references to “dollars” or “$” refer to currency
of the United States of America; and (i) when calculating the period of time within or following which any act is to be done,
any notice is to be given or any other action is to be taken, the date which is the reference date in such period shall be excluded
and if the last day of such period is not a business day, then such period shall end on the next succeeding day that is a business
day.

 

6.2             
Fees and Expenses. Each of the Company, on the one hand, and the Investors, on the other hand, shall pay all of their
respective expenses incurred in connection with the preparation, execution and delivery of the Transaction Documents and the consummation
of the transactions contemplated thereby; provided, however, that the Company shall pay, and hold the Investors, their Affiliates
and each of their representatives harmless against all liability for the payment of (i)  the reasonable and properly
documented fees and charges of Akin Gump Strauss Hauer & Feld LLP, counsel to the Investors, up to a maximum amount of $25,000
that are incurred in connection with the consummation of the transactions contemplated thereby, including the preparation, execution
and delivery of the Transaction Documents and (ii) any stamp or similar taxes which may be determined to be payable in connection
with the execution and delivery and performance of any Transaction Document or any modification, amendment or alteration of any
Transaction Document, and all issue taxes in respect of the issuance of any Purchased Securities.

 

6.3             
Assignment; Parties in Interest. This Agreement shall bind and inure to the benefit of the parties and each of their
respective successors and permitted assigns. The Company may not assign either this Agreement or any of its rights, interests,
or obligations hereunder. Each Investor may assign any of its rights, interests or obligations hereunder, only following the Closing;
provided, however, that the transferee agrees in writing to be bound by, and entitled to the benefits of, this Agreement as an
original party hereto. In the event that such Investor shall assign only a portion of its rights pursuant to this Agreement, or
assign its rights pursuant to this Agreement in connection with the transfer of less than all of its Offered Shares, such Investor
shall also retain its rights with respect to its remaining Offered Shares.

 

    8

     

    

 

6.4             
Entire Agreement; Severability. The Transaction Documents contain the entire understanding of the parties with respect
to the subject matter hereof and thereof and supersede all prior agreements and understandings among the parties with respect to
such subject matters. It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest
extent permissible under the law and public policies applied in each jurisdiction in which enforcement is sought. Accordingly,
in the event that any provision of this Agreement would be held in any jurisdiction to be invalid, prohibited or unenforceable
for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of
this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing,
if such provision could be more narrowly drawn so as not be invalid, prohibited or unenforceable in such jurisdiction, it shall,
as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the
validity or enforceability of such provision in any other jurisdiction.

 

6.5             
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person,
except the Investor Indemnitees and Company Indemnitees are intended third party beneficiaries of Article 6 hereof.

 

6.6             
Notices. All notices, claims, certificates, requests, demands and other communications hereunder shall be in writing
and shall be deemed to have been duly given if personally delivered or if sent by nationally-recognized overnight courier, or by
registered or certified mail, return receipt requested and postage prepaid, addressed as follows:

 

if to the Company:

 

BioScrip, Inc.

1600 Broadway, Suite 950

Denver, CO 80202

Attention: Dan Greenleaf, President and CEO

 

with a copy to:

 

Dechert LLP

1095 Avenue of the Americas

New York, NY 10036

Attention: Scott Zimmerman

 

if to the Investors

 

Venor Capital Management LP

7 Times Square, Suite 4303

New York, NY 10036

Attention: Josh Brodman

 

    9

     

    

 

with a copy to:

 

Akin Gump Strauss Hauer & Feld LLP

One Bryant Park

Bank of America Tower

New York, NY 10036

Attention: Jeffrey L. Kochian

 

or to such other address as the party to
whom notice is to be given may have furnished to the other parties in writing in accordance herewith. Any such notice or communication
shall be deemed to have been received (a) in the case of personal delivery, on the date of such delivery if a business day
or, if not a business day, the next succeeding business day, (b) in the case of nationally-recognized overnight courier, on
the next business day after the date when sent, and (c) in the case of registered or certified mail, return receipt requested
and postage prepaid, on the third business day after the date when sent.

 

6.7             
Amendments; Waivers. The terms and provisions of this Agreement may only be modified or amended pursuant to an instrument
signed by the Company and the Investors. Any waiver of any term or provision of this Agreement requested by any party hereto must
be granted in advance, in writing, by the Company (if an Investor is requesting such waiver) or by the holders of at least a majority
of the Offered Shares outstanding at the time of such waiver (if the Company is requesting such waiver), as the case may be.

 

6.8             
Counterparts. This Agreement may be executed in any number of original or facsimile counterparts, and each such counterpart
shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement. Any such counterpart
may be delivered by facsimile, “pdf” or other form of electronic transmission and such delivery shall be deemed to
be the physical delivery of a manually executed counterpart.

 

6.9             
Headings. The section and paragraph headings contained in this Agreement are for reference purposes only and shall
not affect in any way the meaning or interpretation of this Agreement.

  

6.10         
Governing Law; Consent to Jurisdiction and Venue; Waiver of Jury Trial. This Agreement shall be governed by and construed
in accordance with the laws of the State of New York, without giving effect to any law or rule that would cause the laws of any
jurisdiction other than the State of New York to be applied. ANY PROCEEDING AGAINST THE PARTIES RELATING IN ANY WAY TO THIS AGREEMENT
SHALL BE BROUGHT AND ENFORCED IN THE COURTS OF THE STATE OF NEW YORK SITTING IN THE BOROUGH OF MANHATTAN IN THE CITY OF NEW YORK
OR THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, TO THE EXTENT SUBJECT MATTER JURISDICTION EXISTS THEREFOR,
AND THE PARTIES IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT OF ANY SUCH PROCEEDING. EACH OF THE PARTIES
IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION THAT THEY MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE
OF ANY SUCH PROCEEDING IN THE COURTS OF THE STATE OF NEW YORK LOCATED IN NEW YORK COUNTY OR THE SOUTHERN DISTRICT OF NEW YORK AND
ANY CLAIM THAT ANY SUCH PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN ANY INCONVENIENT FORUM. ANY JUDGMENT MAY BE ENTERED
IN ANY COURT HAVING JURISDICTION THEREOF. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY
PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT.

 

[Remainder of page intentionally left blank;
signatures on next succeeding page.]

 

    10

     

    

 

IN WITNESS WHEREOF,
the parties have executed and delivered this Stock Purchase Agreement on the date first above written.

 

	 	BIOSCRIP, INC.
	 	 	 	 
	 	 	 	 
	 	By:  	/s/  Kathryn Stalmack
	 	 	Name:  	 Kathryn Stalmack
	 	 	Title:	SVP & General Counsel

 

    
SIGNATURE PAGE TO STOCK PURCHASE AGREEMENT

     

    

 

	 	VENOR CAPITAL MASTER FUND LTD.
	 	 	 
	 	By:	Venor Capital Management LP
	 	 	 
	 	Its:	Investment Manager
	 	 	 
	 	By:	/s/ Michael Wartell
	 	Name:	 Michael Wartell
	 	Title:	Co-CIO
	 	 	 
	 	 	 
	 	MAP 139 SEGREGATED PORTFOLIO OF LMA SPC
	 	 	 
	 	By:	Venor Capital Management LP
	 	 	 
	 	Its:	Investment Advisor
	 	 	 
	 	By:	/s/  Michael Wartell
	 	Name:  	 Michael Wartell
	 	Title:	Co-CIO
	 	 	 
	 	 	 
	 	VENOR SPECIAL SITUATIONS FUND II LP
	 	 
	 	By:	Venor Capital Management LP
	 	 	 
	 	Its:	Investment  Manager
	 	 	 
	 	By:	/s/  Michael Wartell
	 	Name:	 Michael Wartell
	 	Title:	Co-CIO
	 	 	 
	 	 	 
	 	TREVITHICK LP
	 	 
	 	By:	Venor Capital Management LP
	 	 	 
	 	Its:	Investment  Manager
	 	 	 
	 	By:	/s/  Michael Wartell
	 	Name:	 Michael Wartell
		Title: 
	Co-CIO

 

    
SIGNATURE PAGE TO STOCK PURCHASE AGREEMENT

     

    

 

SCHEDULE 1.2

 

	Name of Investor	Investor’s Allocation
	VENOR CAPITAL MASTER FUND LTD.	635,885.00
	MAP 139 SEGREGATED PORTFOLIO OF LMA SPC	122,015.00
	VENOR SPECIAL SITUATIONS FUND II LP	1,362,583.00
	TREVITHICK LP	1,179,517.00 
	Total:	3,300,000.00

  

     

     

    

 

INDEX OF DEFINED TERMS

 

	
        Agreement
	Preamble
	Charter Documents	Section 2.5
	Closing	Section 1.4
	Closing Date	Section 1.4
	Common Stock	Recitals
	Company	Preamble
	Company Indemnitees	Section 5.2
	Exchange Act	Section 2.1
	Governmental Authority	Section 2.6
	Investor	Preamble
	Investor Indemnitees	Section 5.1
	Investor’s Allocation	Section 1.2
	Investors	Preamble
	Material Adverse Effect	Section 2.2
	NASDAQ	Section 1.1
	Offering	Recitals
	Per Share Purchase Price	Section 1.3
	Purchased Securities	Section 1.1
	Shares Purchase Price	Section 1.3
	Transaction Documents	Section 2.3
	Transactions	Section 2.3zeus20161231_10k.htm

Exhibit 4.26

 

FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT

 

This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Amendment”) is entered into as of October 30, 2015 by and among OLYMPIC STEEL, INC., an Ohio corporation (“Olympic Steel”), OLYMPIC STEEL LAFAYETTE, INC., an Ohio corporation (“Olympic Lafayette”), OLYMPIC STEEL MINNEAPOLIS, INC., a Minnesota corporation (“Olympic Minneapolis”), OLYMPIC STEEL IOWA, INC., an Iowa corporation (“Olympic Iowa”), OLY STEEL WELDING, INC., a Michigan corporation (“Oly Welding”), OLY STEEL NC, INC., a Delaware corporation (“Oly NC”), TINSLEY GROUPPS& W, INC., a North Carolina corporation (“Tinsley Group”), IS ACQUISITION, INC., an Ohio corporation (“IS Acquisition”), CHICAGO TUBE AND IRON COMPANY, a Delaware corporation (“Chicago Tube and Iron”) (Olympic Steel, Olympic Lafayette, Olympic Minneapolis, Olympic Iowa, Oly Welding, Oly NC, Tinsley Group, IS Acquisition and Chicago Tube and Iron, collectively, “Borrowers”), BANK OF AMERICA, N.A., a national banking association, as agent for Lenders (together with its successors and assigns, “Agent”), and Lenders party hereto.

 

RECITALS

 

A.     Borrowers, Lenders and Agent are party to that certain Second Amended and Restated Loan and Security Agreement, dated as of June 30, 2014 (as such agreement may be amended, restated, or otherwise modified from time to time, the “Loan Agreement”) pursuant to which Lenders have agreed to make certain loans and extend certain other financial accommodations to Borrowers as provided therein. Terms defined in the Loan Agreement, where used in this Amendment, shall have the same meanings in this Amendment as are prescribed by the Loan Agreement.

 

B.      Borrowers have requested that Lenders amend certain terms of the Loan Agreement as set forth herein.

 

NOW, THEREFORE, in consideration of the terms and conditions contained herein, and of any loans or financial accommodations heretofore, now, or hereafter made to or for the benefit of Borrowers by Lenders, it hereby is agreed as follows:

 

 

ARTICLE 1

 

AMENDMENTS TO LOAN AGREEMENT

 

Section 1.1      Amendments. The Loan Agreement is hereby amended as follows (with the deletions of the stricken text (if any) indicated in the same manner as the following example: stricken text and with the insertions of additional text (if any) indicated in the same manner as the following example: bold and italics text in the cases of amendments that restate or replace provisions, phrases or other text):

 

(a)      The following new defined term is inserted in Section 1.1 of the Loan Agreement in its appropriate alphabetical order: 

 

First Amendment Date: October 30, 2015.

 

(b)      The defined term “Tranche A Revolver Commitment” is amended and restated to read in its entirety as follows:

 

Tranche A Revolver Commitment: for any Lender, its obligation to make Tranche A Revolver Loans and to participate in LC Obligations up to the maximum principal amount shown on Schedule 1.1 (subject to any increase permitted pursuant to Section 2.1.7 and subject to increase pursuant to the second succeeding sentence), or as hereafter determined pursuant to each Assignment and Acceptance to which it is a party. “Tranche A Revolver Commitments” means the aggregate amount of such commitments of all Tranche A Revolver Lenders. Tranche A Revolver Commitments of each Tranche A Revolver Lender that is also a Tranche B Revolver Lender shall be increased automatically and permanently (in an amount, with respect to each such increase and with respect to each such Lender, that is equal to the amount of the substantially contemporaneous reduction in such Lender’s Tranche B Revolver Commitment pursuant to the third sentence of the definition of the term “Tranche B Revolver Commitments”) in (i) an amount equal to $3,125,000 on June 30, 2015, (ii) an amount equal to $2,430,555.56 on the First Amendment Date, and (iii) equal quarterly amounts, each equal to $2,777,777.78, commencing on December 31, 2015 the last Business Day of the calendar quarter in which the first anniversary of the Closing Date occurs and continuing on the last Business Day of each calendar quarter in which the first anniversary of the Closing Date occurs and continuing on the last Business Day of each calendar quarter thereafter until the aggregate amount of all such increases equals $25,000,000.

 

 

 

 

  

(c)      The defined term “Tranche B Revolver Commitment” is amended and restated to read in its entirety as follows:

 

Tranche B Revolver Commitment: for any Lender, its obligation to make Tranche B Revolver Loans up to the maximum principal amount shown on Schedule 1.1 (subject to reduction pursuant to the second succeeding sentence), or as hereafter determined pursuant to each Assignment and Acceptance to which it is a party. “Tranche B Revolver Commitments” means the aggregate amount of such commitments of all Tranche B Revolver Lenders. Tranche B Revolver Commitments shall be reduced automatically and permanently (on a Pro Rata basis for each Tranche B Revolver Lender) (a) in (i) an amount equal to $3,125,000 on June 30, 2015, (ii) an amount equal to $2,430,555.56 on the First Amendment Date, and (iii) equal quarterly amounts, each equal to $2,777,777.78, commencing on December 31, 2015 the last Business Day of the calendar quarter in which the first anniversary of the Closing Date occurs, and continuing on the last Business Day of each calendar quarter thereafter until reduced to zero ($0) and (b) reduced to zero ($0) upon the earlier to occur of (i) the date on which the Tranche B Revolver Commitments shall be reduced in full and (ii) the Tranche B Revolver Termination Date or such earlier date on which the Tranche B Revolver Commitments are terminated in accordance with this Agreement.

 

 

ARTICLE 2

 

MISCELLANEOUS

 

Section 2.1      Conditions to Effectiveness. This Amendment shall become effective on the date upon satisfaction or waiver of the following conditions precedent, as determined by Agent in its sole discretion:

 

(a)      this Amendment shall have been duly executed and delivered by Agent, each Borrower and each Lender;

 

(b)      Borrowers shall have paid all fees and expenses to be paid to Agent and Lenders required to be paid pursuant to Section 3.4 of the Loan Agreement; and

 

(c)     all representations and warranties of Borrowers contained herein shall be true and correct in all respects.

 

Section 2.2      Representations, Warranties, and Covenants of Borrowers. Each Borrower hereby represents and warrants that as of the date of this Amendment and after giving effect hereto (a) no event has occurred and is continuing which, after giving effect to this Amendment, constitutes a Default or an Event of Default, (b) the representations and warranties of such Borrower contained in the Loan Agreement and the other Loan Documents are true and correct in all material respects on and as of the date hereof to the same extent as though made on and as of the date hereof, except to the extent such representations and warranties specifically relate to an earlier date, in which case they are true and correct in all material respects as of such earlier date, (c) the execution and delivery by such Borrower of this Amendment and the performance by such Borrower of the Loan Agreement, as amended by this Amendment, are within such Borrower’s corporate powers and have been duly authorized by all necessary action, (d) this Amendment and the Loan Agreement, as amended by this Amendment, are legal, valid, and binding obligations of such Borrower enforceable against such Borrower in accordance with their terms, except to the extent that the enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws generally affecting creditors’ rights and by equitable principles (regardless of whether enforcement is sought in equity or at law), and (e) the execution and delivery by such Borrower of this Amendment and the performance by such Borrower of the Loan Agreement, as amended by this Amendment, do not require the consent of any Person (other than that which has been obtained) and do not contravene the terms of such Borrower’s Organic Documents, any Restrictive Agreement or any other indenture, agreement, or undertaking to which such Borrower is a party or by which such Borrower or any of its property is bound.

 

 

 

 

  

Section 2.3      Reference to and Effect on the Loan Agreement. Except as expressly provided herein, the Loan Agreement and all other Loan Documents shall remain unmodified and in full force and effect and are hereby ratified and confirmed. The execution, delivery, and effectiveness of this Amendment shall not operate as a waiver or forbearance of (a) any right, power, or remedy of Lenders under the Loan Agreement or any of the other Loan Documents or (b) any Default or Event of Default. This Amendment shall constitute a Loan Document.

 

Section 2.4      Fees, Costs, and Expenses. Subject to and in accordance with Section 3.4 of the Loan Agreement, Borrowers agree to pay on demand all reasonable costs and expenses of Agent in connection with the preparation, negotiation, execution and delivery, and closing of this Amendment and all related documentation, including the fees and out-of-pocket expenses of counsel for Agent with respect thereto. 

 

Section 2.5      Counterparts. This Amendment may be executed in any number of counterparts and by different parties hereto as separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original and all of which counterparts, when taken together, shall constitute but one and the same agreement. A telecopy, pdf or similar electronic file of any such executed counterpart shall be deemed valid and may be relied upon as an original.

 

Section 2.6      Effect; Ratification.

 

(a)      Except as specifically set forth above, the Loan Agreement and the other Loan Documents shall remain in full force and effect and are hereby ratified and confirmed. 

 

(b)      The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of Agent or any Lender under the Loan Agreement or any other Loan Document, nor constitute amendment of any provision of the Loan Agreement or any other Loan Document, except as specifically set forth herein. Upon the effectiveness of this Amendment, each reference in the Loan Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or words of similar import shall mean and be a reference to the Loan Agreement as amended hereby.

 

(c)      Each Borrower acknowledges and agrees that the amendments set forth herein are effective solely for the purposes set forth herein and that the execution and delivery by Agent and Lenders of this Amendment shall not be deemed (i) except as expressly provided in this Amendment, to be a consent to any amendment, waiver or modification of any term or condition of the Loan Agreement or of any other Loan Document, (ii) to create a course of dealing or otherwise obligate Agent or Lenders to forbear, waive, consent or execute similar amendments under the same or similar circumstances in the future, or (iii) to amend, prejudice, relinquish or impair any right of Agent or Lenders to receive any indemnity or similar payment from any Person or entity as a result of any matter arising from or relating to this Amendment.

 

Section 2.7      Reaffirmation. Each Borrower hereby acknowledges and reaffirms all of its obligations and undertakings under each of the Loan Documents to which it is a party and acknowledges and agrees that subsequent to, and after taking account of the provisions of this Amendment, each such Loan Document is and shall remain in full force and effect in accordance with the terms thereof.

 

Section 2.8      No Oral Agreements. THIS WRITTEN AGREEMENT REPRESENTS THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES.

 

Section 2.9      GOVERNING LAW. THIS AMENDMENT, UNLESS OTHERWISE SPECIFIED, SHALL BE GOVERNED BY THE LAWS OF THE STATE OF ILLINOIS, WITHOUT GIVING EFFECT TO ANY CONFLICT OF LAW PRINCIPLES (BUT GIVING EFFECT TO FEDERAL LAWS RELATING TO NATIONAL BANKS).

 

[Signature Pages Follow]

 

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the day and year first written above.

 

	
 
	
BORROWERS:

 

OLYMPIC STEEL, INC.
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Treasurer
	
 

 

	
 
	
OLYMPIC STEEL LAFAYETTE, INC.
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Treasurer
	
 

 

	
 
	
OLYMPIC STEEL MINNEAPOLIS, INC.
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Treasurer
	
 

 

	
 
	OLYMPIC STEEL MINNEAPOLIS, INC.	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Treasurer
	
 

 

	
 
	OLYMPIC STEEL IOWA, INC.	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Treasurer
	
 

 

	
 
	OLY STEEL WELDING, INC.	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Secretary
	
 

 

	
 
	OLY STEEL NC, INC.	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Treasurer
	
 

 

	
 
	TINSLEY GROUP-PS&W, INC.	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	Treasurer	
 

 

	
 
	IS ACQUISITION, INC	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Secretary
	
 

 

	
 
	CHICAGO TUBE AND IRON COMPANY	
 

	
 
	
 
	 	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Richard A. Manson
	
 

	
 
	
Title:
	
Treasurer
	
 

 

 

 

 

 

	
 
	
AGENT AND LENDERS:

 

BANK OF AMERICA, N.A.,

as Agent and Lender
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Thomas H. Herron
	
 

	
 
	
Title:
	
Senior Vice President
	
 

 

 

	
 
	
CAPTIAL ONE BUSINESS CREDIT CORP.,

as Lender
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Edward Behnen
	
 

	
 
	
Title:
	
Vice President
	
 

 

 

	
 
	
COMERICA BANK,

as Lender
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Andrew Roy
	
 

	
 
	
Title:
	
Vice President
	
 

 

 

	
 
	
THE HUNTINGTON NATIONAL BANK,

as Lender
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Roger Redder
	
 

	
 
	
Title:
	
Vice President
	
 

  

 

	
 
	
JPMORGAN CHASE BANK, N.A.,

as Lender
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Tim Kenealy
	
 

	
 
	
Title:
	
Authorized Signatory
	
 

 

 

	
 
	
KEY BANK NATIONAL ASSOCIATION,

as Lender
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Paul Steiger
	
 

	
 
	
Title:
	
Vice President
	
 

 

 

	
 
	
U.S. BANK NATIONAL ASSOCIATION,

as Lender
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Matthew Kasper
	
 

	
 
	
Title:
	
Vice President
	
 

 

 

 

 

 

	
 
	
WELLS FARGO BANK NATIONAL ASSOCIATION,

as Lender
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By: 
	
/s/ Mark Bradford
	
 

	
 
	
Title:
	
Duly Authorized Signatory

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}]]